Trump Wins… But Elon Says Get Ready to Brace

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

Ken Vroman Biography and Net Worth

Insider of CME Group

Kendal (Ken) Vroman serves as CME Group’s Chief Transformation Officer. He is responsible for overseeing the company’s migration process as part of its 10-year partnership with Google Cloud to transform global derivatives markets through cloud adoption. He also leads the planning and execution function across the organization. Prior to assuming his current role, he most recently served as Senior Managing Director, International and Optimization Services.

Since joining the company in 2001, Vroman has held a variety of senior leadership roles including Managing Director, Planning and Execution, Global Head, Commodity Products and OTC Solutions, and Managing Director and Chief Corporate Development Officer.

Before joining the company, he worked as Vice President, Corporate Operations/Chief of Staff to the Chief Executive Officer for marchFIRST Inc. He also served as Principal for Whittman-Hart’s Collaborative Technologies Group and as a Senior Consultant for Andersen Consulting LLP’s Americas Information Systems Division.

What is Ken Vroman's net worth?: The estimated net worth of Ken Vroman is at least $2.86 million as of September 12th, 2022. Mr. Vroman owns 12,486 shares of CME Group stock worth more than $2,859,793 as of November 22nd. This net worth estimate does not reflect any other assets that Mr. Vroman may own. Learn More about Ken Vroman's net worth.
How do I contact Ken Vroman?: The corporate mailing address for Mr. Vroman and other CME Group executives is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. CME Group can also be reached via phone at (312) 930-1000 and via email at [email protected]. Learn More on Ken Vroman's contact information.
Has Ken Vroman been buying or selling shares of CME Group?: Ken Vroman has not been actively trading shares of CME Group in the last ninety days. Most recently, Ken Vroman sold 750 shares of the business's stock in a transaction on Monday, September 12th. The shares were sold at an average price of $201.41, for a transaction totalling $151,057.50. Following the completion of the sale, the insider now directly owns 12,486 shares of the company's stock, valued at $2,514,805.26. Learn More on Ken Vroman's trading history.
Who are CME Group's active insiders?: CME Group's insider roster includes Timothy Bitsberger (Director), Charles Carey (Director), Elizabeth Cook (Director), Kathleen Cronin (Insider), Sunil Cutinho (Insider), Terrence Duffy (Chairman & CEO), Bryan Durkin (Director), Lynne Fitzpatrick (Senior Managing Director & Deputy CFO), Martin Gepsman (Director), Phupinder Gill (CEO), Daniel Glickman (Director), Julie Holzrichter (COO), Kevin Kometer (Insider), Timothy McCourt (Insider), Hilda Piell (Insider), John Pietrowicz (CFO), Derek Sammann (Insider), Terry Savage (Director), Terry Savage (Director), William Shepard (Director), Howard Siegel (Director), Dennis Suskind (Director), Jack Tobin (CAO), Sean Tully (Insider), Ken Vroman (Insider), and Julie Winkler (Insider). Learn More on CME Group's active insiders.
Are insiders buying or selling shares of CME Group?: In the last year, CME Group insiders bought shares 5 times. They purchased a total of 109 shares worth more than $22,402.94. In the last year, insiders at the financial services provider sold shares 16 times. They sold a total of 88,049 shares worth more than $18,813,672.55. The most recent insider tranaction occured on November, 4th when Director Martin J Gepsman sold 400 shares worth more than $89,168.00. Insiders at CME Group own 0.3% of the company. Learn More about insider trades at CME Group.
Information on this page was last updated on 11/4/2024.

Ken Vroman Insider Trading History at CME Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/12/2022	Sell	750	$201.41	$151,057.50	12,486
11/9/2021	Sell	445	$220.00	$97,900.00
11/2/2020	Sell	4,541	$152.63	$693,092.83	9,879
3/12/2013	Sell	1,492	$62.69	$93,533.48

Ken Vroman Buying and Selling Activity at CME Group

CME Group Company Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

Today's Range

Now: $229.04

$226.91

$229.94

50 Day Range

MA: $223.64

$213.16

$229.69

2 Week Range

Now: $229.04

$190.70

$230.74

Volume

3,049,526 shs

Average Volume

1,917,887 shs

Market Capitalization

$82.54 billion

P/E Ratio

24.08

Dividend Yield

2.00%

Beta

0.55